PHARMACEUTICAL COMPOSITION COMPRISING APOLIPOPROTEINS FOR THE TREATMENT OF HUMAN DISEASES

摘要

The present invention is related to a pharmaceutical composition comprising an adequate pharmaceutical carrier or diluent and an element selected from the group consisting of a pharmaceutical composition comprising an adequate pharmaceutical carrier or diluent and an element selected from the group consisting of : - apolipoprotein apoL-III; - a pharmaceutically active fragment of this apolipoprotein apoL-III; - a nucleotide sequence encoding this apolipoprotein apoL-III or said fragment; - a vector comprising said nucleotide sequence; - a cell transformed by said nucleotide sequence or said vector; - an inhibitor or activator directed against said apolipoprotein apoL-III, its fragment or its nucleotide sequence, - an anti-inhibitor or anti-activator directed against said inhibitor or activator or its encoding nucleotide sequence.